Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
Moderate quality score of 55/100, reflecting stable operating margins and manageable leverage.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Average quality business weighed down by significant profitability concerns.
Wall Street sentiment is generally neutral. This is paired with healthy capital returns, anchored by a strong, well-covered dividend yield.
SWBI demonstrates adequate business quality with stable profitability. This is paired with a moderately leveraged but stable balance sheet.
The company exhibits steady, low-single-digit revenue growth however, earnings have severely contracted over the same period. Operating efficiency remains adequate with margins around 5.6%.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $178.4M | +10.4% | +3.0% | -13.1% | -3.2% | |
| EBITDA | $29.2M | — | -9.2% | — | — | |
| Net Income | $16.2M | +37.7% | -20.6% | — | -15.0% | |
| EPS (Diluted) | $0.36 | +36.7% | -20.0% | -38.2% | -13.2% | |
| Free Cash Flow | $70.3M | +493.6% | — | -17.2% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 26.9% | 27.7% | 31.8% | 34.5% |
| Operating Margin | 5.6% | 6.3% | 11.6% | 12.8% |
| Net Margin | 3.5% | 4.6% | 8.8% | 7.9% |
| FCF Margin | 20.3% | 6.2% | 3.3% | 7.6% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.23 | $0.36 | +60.0% | ||
| Q1'26 | $0.04 | $0.08 | +77.8% | ||
| Q4'25 | $0.05 | $0.04 | -20.0% | ||
| Q3'25 | $0.02 | $-0.08 | -500.0% | ||
| Q2'25 | $0.23 | $0.20 | -13.0% | ||
| Q1'25 | $0.02 | $0.02 | +0.0% | ||
| Q4'24 | $0.16 | $0.11 | -31.3% | ||
| Q3'24 | $-0.02 | $-0.02 | +0.0% |
Total return is +52.6% (1Y), outperforming the benchmark by +27.6%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +62.4% | +53.1% | — |
| 1Y | +52.6% | +27.6% | +4.8% |
| 3YCAGR | +14.8% | -10.1% | +13.1% |
| 5YCAGR | -4.7% | -16.8% | +9.6% |
| 10YCAGR | -0.1% | -14.8% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Smith & Wesson Brands, Inc. (SWBI) valuation, health, and returns.
Based on peer relative multiples, Smith & Wesson Brands, Inc. appears Cheap versus peers compared to industry peers.
Smith & Wesson Brands, Inc. has multiple valuation anchors: Peer Relative Fair Value: $48.48 | Wall Street Analyst Target: $16.50 (implying +2.6% upside). A convergence of these signals offers higher conviction.
Smith & Wesson Brands, Inc. displays fair financial health with a composite quality score of 55/100, supported by a Altman Z-Score of 5.6 (safe zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 5.0%.
Smith & Wesson Brands, Inc. pays a 3.2% dividend yield, covered by a 126% payout ratio with 6 years of growth, supplemented by a 0.2% buyback yield.
Smith & Wesson Brands, Inc.'s current growth trajectory is Accelerating. The company achieved +10.4% 1Y revenue growth and +36.7% 1Y EPS growth, compared to its 3Y revenue CAGR of +3.0%.
Wall Street consensus is Buy based on 4 analysts, beating EPS expectations in 42% of recent quarters with a 2-quarter streak. The consensus price target represents a +2.6% change from current levels.
Investment risks for Smith & Wesson Brands, Inc. include: -20.8% 1-year max drawdown, stretched payout ratio. Volatility risk is characterized by a beta of 0.68x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.